Captrust Financial Advisors Vor Biopharma Inc. Put Options Transaction History
Captrust Financial Advisors
- $43.1 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VOR
# of Institutions
42Shares Held
55.7MCall Options Held
4.15MPut Options Held
364K-
Ra Capital Management, L.P. Boston, MA39.6MShares$999 Million1.4% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$160 Million6.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$48.3 Million0.0% of portfolio
-
Ubs Group Ag1.53MShares$38.6 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$27.1 Million0.59% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $959M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...